Lynx1 Capital Management LP, Ten Percent Owner at TScan Therapeutics, holds 5.22M shares in TScan Therapeutics (Ticker: TCRX). Most recently, Lynx1 Capital Management LP Sold $25,400 shares of TScan Therapeutics on Jun 02, 2023 for an estimated value of 63.90K.

See the Hottest Stocks Based on Insider Trading >

Lynx1 Capital Management LP
TScan Therapeutics (TCRX)
Ten Percent Owner

Not Ranked

Lynx1 Capital Management LP has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

TCRX

A breakdown of Lynx1 Capital Management LP's holdings

See the Top Stocks by Insiders

Insider Roles

TScan Therapeutics
(TCRX)

Ten Percent Owner

Roles that Lynx1 Capital Management LP holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Currently, no data available

The most profitable trade made by Lynx1 Capital Management LP

See the Latest Stocks Traded by Insiders

Lynx1 Capital Management LP's Trading History

TCRX

TScan Therapeutics

Jun 02, 2023

Ten Percent Owner

Informative Sell

63.90K

$41.85M

Jun 02, 2023

Informative Sell

$63.90K

$2.51

―

List of latest transactions for each holding click on a transaction to see Lynx1 Capital Management LP's performance on stock

See All Insider Trading from Today

Lynx1 Capital Management LP insider profile FAQ

What is the percentage of profitable transactions made by Lynx1 Capital Management LP?

The percentage of profitable transactions made by Lynx1 Capital Management LP is ―.

What is the average return per transaction made by Lynx1 Capital Management LP?

The average return per transaction made by Lynx1 Capital Management LP is ―.

What stocks does Lynx1 Capital Management LP hold?

Lynx1 Capital Management LP holds: TCRX stocks.

What was Lynx1 Capital Management LP’s latest transaction?

Lynx1 Capital Management LP latest transaction was an Informative Sell of $63.90K.

What was Lynx1 Capital Management LP's most profitable transaction?

Lynx1 Capital Management LP’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.

What is Lynx1 Capital Management LP's role in TScan Therapeutics?

Lynx1 Capital Management LP's role in TScan Therapeutics is Ten Percent Owner.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Lynx1 Capital Management LP Insider Profile

Lynx1 Capital Management LP TScan Therapeutics (TCRX)Ten Percent Owner